Back

Timing and magnitude of the next wave of COVID-19 in China:lessons from 189 countries and territories

Niu, B.; Ji, S.; Zhao, S.; Lei, H.

2023-03-29 public and global health
10.1101/2023.03.27.23287793 medRxiv
Show abstract

Because of the fading immunity to COVID-19 and continuous evolution of the SARS-CoV-2 Omicron variants, the next epidemic wave of COVID-19 is inevitable. The Omicron variant has been the cause of several waves of the COVID-19 epidemics in the majority of countries. Thus, lessons from other countries may provide guidance regarding the timing and magnitude of the next COVID-19 wave of the pandemic in China. In this study, the COVID-19 surveillance data from 189 countries that experienced two or more waves of the SARS-CoV-2 Omicron variant were analysed. The median peak timing between the first and second/third waves of the SARS-CoV-2 Omicron variant was 164/243 days. The peaks of the second and third waves were much lower than that of the first wave. The median relative peaks of the second and third compared with the first waves were 14.5% and 11.2%, respectively. The time window between the peak timings of the first and second waves showed no significant rank correlation with the five socioeconomic factors included in this study. However, the relative peak of the second wave increased significantly with gross domestic product per capita (P<0.001), urbanisation rate (P=0.003), population density (P=0.007), and proportion of older adults >65 years (P<0.001), although decreased significantly with the proportion of 0-14 teenagers (P<0.001). In summary, the historical situations and progression of COVID-19 outbreaks in other countries may inform the risk assessment of incoming outbreaks in mainland China; however, the timing and magnitude of the next COVID-19 wave may also be influenced by several unknown factors, including rapid viral evaluation of SARS-CoV-2

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Public Health
140 papers in training set
Top 0.1%
23.2%
2
PLOS ONE
4510 papers in training set
Top 12%
14.8%
3
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.1%
5.0%
4
eLife
5422 papers in training set
Top 16%
5.0%
5
Frontiers in Medicine
113 papers in training set
Top 0.9%
4.4%
50% of probability mass above
6
International Journal of Infectious Diseases
126 papers in training set
Top 0.4%
4.1%
7
Clinical Infectious Diseases
231 papers in training set
Top 1%
3.7%
8
JMIR Public Health and Surveillance
45 papers in training set
Top 1%
2.4%
9
International Journal of Environmental Research and Public Health
124 papers in training set
Top 3%
2.4%
10
BMJ Open
554 papers in training set
Top 9%
1.7%
11
BMC Public Health
147 papers in training set
Top 3%
1.7%
12
Journal of Medical Virology
137 papers in training set
Top 2%
1.7%
13
Environmental Research
46 papers in training set
Top 0.9%
1.5%
14
The Innovation
12 papers in training set
Top 0.4%
1.4%
15
Science of The Total Environment
179 papers in training set
Top 4%
1.3%
16
Scientific Reports
3102 papers in training set
Top 65%
1.3%
17
PeerJ
261 papers in training set
Top 10%
1.3%
18
Journal of Infection
71 papers in training set
Top 2%
1.3%
19
Emerging Microbes & Infections
74 papers in training set
Top 1%
1.0%
20
Infectious Diseases of Poverty
10 papers in training set
Top 0.3%
0.9%
21
Heliyon
146 papers in training set
Top 4%
0.9%
22
Epidemiology and Infection
84 papers in training set
Top 2%
0.9%
23
BMC Infectious Diseases
118 papers in training set
Top 5%
0.8%
24
Emerging Infectious Diseases
103 papers in training set
Top 2%
0.8%
25
Journal of Genetics and Genomics
36 papers in training set
Top 2%
0.8%
26
BMC Medicine
163 papers in training set
Top 7%
0.8%
27
The Lancet Infectious Diseases
71 papers in training set
Top 3%
0.8%
28
Frontiers in Neurology
91 papers in training set
Top 5%
0.8%
29
Microbiology Spectrum
435 papers in training set
Top 6%
0.7%
30
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 10%
0.7%